Jia Bin, Xia Lei, Cao Fang
Department of Gastroenterology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.
Department of Oncology, Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan, Shandong 250014, P.R. China.
Exp Ther Med. 2018 Mar;15(3):2569-2574. doi: 10.3892/etm.2018.5716. Epub 2018 Jan 8.
Colorectal cancer (CRC) develops from the colon or rectum and is the fourth highest inducer of cancer mortality. In the present study, cancer tissues and normal tissues were extracted from patients with CRC who were treated in the Affiliated Hospital of Shandong University of Traditional Chinese Medicine (Jinan, China). Reverse transcription-quantitative polymerase chain reaction demonstrated that the expression level of miR-766-5p was significantly higher (P<0.01) in cancer tissue than that in normal tissue. SW480 cells were used for study and randomly separated into the miR-negative control (NC) inhibitor treatment group and miR-766-5p inhibitor treatment group. SW480 cell behaviors were evaluated. Results demonstrated that in the miR-766-5p inhibitor group, there was a decreased level of cell proliferation/migration/invasion and higher cell apoptosis compared with that in the miR-NC inhibitor group. miR-766-5p was predicted and verified to target the 3' untranslated region of suppressor of cancer cell invasion (SCAI) in SW480 cells. Protein expression levels of matrix metalloproteinase-2/phosphoinositide 3-kinase/AKT were decreased and SCAI was increased following miR-766-5p inhibitor treatment. In conclusion, the present study indicated that miR-766-5p inhibitor repressed the process of CRC by targeting SCAI.
结直肠癌(CRC)起源于结肠或直肠,是癌症死亡的第四大诱因。在本研究中,从山东中医药大学附属医院(中国济南)接受治疗的CRC患者中提取癌组织和正常组织。逆转录-定量聚合酶链反应表明,miR-766-5p在癌组织中的表达水平显著高于正常组织(P<0.01)。使用SW480细胞进行研究,并将其随机分为miR阴性对照(NC)抑制剂治疗组和miR-766-5p抑制剂治疗组。评估SW480细胞行为。结果表明,与miR-NC抑制剂组相比,miR-766-5p抑制剂组的细胞增殖/迁移/侵袭水平降低,细胞凋亡增加。预测并验证miR-766-5p在SW480细胞中靶向癌细胞侵袭抑制因子(SCAI)的3'非翻译区。miR-766-5p抑制剂处理后,基质金属蛋白酶-2/磷酸肌醇3-激酶/AKT的蛋白表达水平降低,SCAI增加。总之,本研究表明miR-766-5p抑制剂通过靶向SCAI抑制CRC的进程。